Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment.

Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
18 Sep 2019
Historique:
entrez: 20 9 2019
pubmed: 20 9 2019
medline: 20 9 2019
Statut: epublish

Résumé

Following publication of the original article [1], the authors reported that one of the authors, Corrado Caracò, has been accidentally omitted from the author list. In this Correction the author has been added to the author list.

Identifiants

DOI: 10.1186/s12967-019-2067-0 PMID: 31533733 PMC: PMC6751610
pubmed: 31533733
doi: 10.1186/s12967-019-2067-0
pii: 10.1186/s12967-019-2067-0
pmc: PMC6751610
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

315

Commentaires et corrections

Type : ErratumFor

Références

J Transl Med. 2019 Aug 14;17(1):266
pubmed: 31412885

Auteurs

Paolo Antonio Ascierto (PA)

Unit Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. paolo.ascierto@gmail.com.

Lorenzo Borgognoni (L)

Ospedale Santa Maria Annunziata and University of Florence, Florence, Italy.

Gerardo Botti (G)

Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy.

Michele Guida (M)

Unit Melanoma and Rare Tumors, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.

Paolo Marchetti (P)

Oncologia Medica B Policlinico Umberto I di Roma, Rome, Italy.

Simone Mocellin (S)

Surgical Oncology Unit, IOV-IRCCS of Padova and Dept. Surgery Oncology Gastroenterology, University of Padova, Padua, Italy.

Paolo Muto (P)

Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy.

Giuseppe Palmieri (G)

Unit of Cancer Genetics, ICB-CNR, Sassari, Italy.
Research Director CNR, Italian Melanoma Intergroup (IMI), Unit of Cancer Genetics, Head Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy.

Roberto Patuzzo (R)

IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Pietro Quaglino (P)

Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy.

Ignazio Stanganelli (I)

Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, FC, Italy.
University of Parma, Parma, Italy.

Corrado Caracò (C)

Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy.

Classifications MeSH